Zelnorm: Lawyers To File Lawsuits Against Novartis for Heart Attacks

Although Novartis has agreed to suspend marketing of the drug in the United States, the battle is just beginning. Zelnorm lawyers are filing on behalf of people have been badly harmed by the side effects of this drug since it was approved in July 2002. While the drug was intended for short-term treatment of women with irritable bowel syndrome (with constipation), it was subsequently approved in August 2004 for treatment of chronic constipation for men and women under age 65. This problem is widespread, as Zelnorm has been marketed in 55 countries.

Our lawyers are now investigating the actions of Novartis as we prepare to file lawsuits for injuries such as heart attacks. We are gathering information about the dangers of Zelnorm and intend to find out what Novartis knew and when they knew it. We want to share this information with our clients.

As a result of what has been shown in recent studies of Zelnorm (generically, tegaserod), the FDA is now advising patients who use Zelnorm to contact their health care providers to discuss treatment alternatives.

Heart Attack Symptoms? Patients who are taking Zelnorm should seek emergency medical care if they experience severe chest pain, shortness of breath, dizziness, sudden onset of weakness or difficulty walking or talking, or other symptoms of a heart attack or stroke.

"This decision reflects the FDA's commitment to continuously monitor approved drugs throughout their marketing life, and take action when we believe the risks exceed the benefits," said Dr. Douglas Throckmorton, Deputy Director for the Center for Drug Evaluation and Research. "Here, a potential risk of very serious harm to patients who have this non-life-threatening condition was recently identified, making this action necessary."

If you think you may have a case against Novartis for Zelnorm side effects, contact us for a free case evaluation.